Drug Combination Details
General Information of the Combination (ID: C57472) | |||||
---|---|---|---|---|---|
Name | Melatonin NP Info | + | Cisplatin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Atrophic vaginitis
[ICD-11: GA30]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | TP53 | Molecule Info |
Pathway MAP
|
|
In-vivo Model | Four-week-old female CD-1 (ICR) mice weighing 20 +/- 2 g were used in this study. | |||||
Experimental
Result(s) |
Melatonin and ghrelin showed synergistic effect on preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27 Kip1 promoter in primordial follicles. |
